A Randomised, Open-Label, Single-Centre, Crossover Study in Healthy Male Volunteers to Assess the Effect of Food on the Pharmacokinetics of a 10 mg Single Oral Dose of ZD4054
Phase of Trial: Phase I
Latest Information Update: 10 Nov 2010
At a glance
- Drugs Zibotentan (Primary)
- Indications Non-small cell lung cancer; Prostate cancer
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 12 Nov 2008 Status changed from active, no longer recruiting to completed.
- 04 Aug 2008 Status changed from recruiting to in progress, as reported by ClinicalTrials.gov.
- 29 Jul 2008 New trial record.